If you're thinking of selling your stocks, you're not alone. Insiders sell for many reasons, ranging from compensation to estate or tax planning to just plain getting out, but the reasons are rarely (if ever) given. Having said that, these are open market sales, made by executives who have 100% control over the timing of their trades. Not so at Varian Medical Systems (NYSE: VAR) and Qualcomm (Nasdaq: QCOM), whose insiders have mostly been cashing in on a predetermined schedule known as a 10b5-1 trading plan.
Firms typically find their way here because those selling either (a) exhibit good timing, or (b) are dumping significant portions of their stakes. Copart director Thomas Smith's selling troubles me for two reasons. First, volume, as he sold a half-million shares over three days last week. Second, he's not the only insider to sell in large chunks. Barry Rosenstein's investment partnership cashed in almost 44% of its Copart stake in December and was selling again this week.
Anticipating a slowdown?
Another Income Investor pick, Heinz. "Just enough variety on this one to pull through, else the rotten veggies will be on me. Solid stable value play. Typically companies like [Heinz] beat the S&P in a recession and stay ahead of the curve slightly on the way back out. Steady dividend and reliable companies can grind through just about anything," wrote CAPS All-Star TSIF recently.
Sound thinking and absolutely correct in principle, although we might have said something similar about General Electric (NYSE: GE) or Citigroup (NYSE: C) not that long ago. Board member Nelson Peltz, an investor by trade, knows this. He liquidated more than 20% of his partnership's stake in Heinz this week and last.
Or did he? Peltz's Form 4 is coded and filed as if to document a series of sales. But the footnotes tell a different story. Quoting from the first footnote: "The price shown in Column 4 is a weighted average purchase price. The price range for the purchases is $36.62 to $37.11." [Italics added.] Other footnotes give ranges of $36.33 to $36.94 and $36.03 to $36.57.
Confused? You and me both. Peltz's investment company, Trian, didn't respond to calls for clarification before deadline but a Heinz spokesperson confirmed that the transactions were sales. Trian also issued a statement in response to a Barron's story in which the firm expressed support for Heinz's plans for growth, which it apparently wouldn't have to do were Peltz and his peers buying.
So Peltz seems to be selling, in bulk, a stock trading for around 12 times earnings and which yields more than 4% in dividends. I'm not that gutsy. To me, that sounds like a stock you buy.
Firms typically find their way here because those selling either (a) exhibit good timing, or (b) are dumping significant portions of their stakes. Copart director Thomas Smith's selling troubles me for two reasons. First, volume, as he sold a half-million shares over three days last week. Second, he's not the only insider to sell in large chunks. Barry Rosenstein's investment partnership cashed in almost 44% of its Copart stake in December and was selling again this week.
Anticipating a slowdown?
Another Income Investor pick, Heinz. "Just enough variety on this one to pull through, else the rotten veggies will be on me. Solid stable value play. Typically companies like [Heinz] beat the S&P in a recession and stay ahead of the curve slightly on the way back out. Steady dividend and reliable companies can grind through just about anything," wrote CAPS All-Star TSIF recently.
Sound thinking and absolutely correct in principle, although we might have said something similar about General Electric (NYSE: GE) or Citigroup (NYSE: C) not that long ago. Board member Nelson Peltz, an investor by trade, knows this. He liquidated more than 20% of his partnership's stake in Heinz this week and last.
Or did he? Peltz's Form 4 is coded and filed as if to document a series of sales. But the footnotes tell a different story. Quoting from the first footnote: "The price shown in Column 4 is a weighted average purchase price. The price range for the purchases is $36.62 to $37.11." [Italics added.] Other footnotes give ranges of $36.33 to $36.94 and $36.03 to $36.57.
Confused? You and me both. Peltz's investment company, Trian, didn't respond to calls for clarification before deadline but a Heinz spokesperson confirmed that the transactions were sales. Trian also issued a statement in response to a Barron's story in which the firm expressed support for Heinz's plans for growth, which it apparently wouldn't have to do were Peltz and his peers buying.
So Peltz seems to be selling, in bulk, a stock trading for around 12 times earnings and which yields more than 4% in dividends. I'm not that gutsy. To me, that sounds like a stock you buy.
No comments:
Post a Comment